Possibility of the use of serological method for the determination of immunoglobuline a antibody against early antigene of Epstein-Barr virus as a marker in the diagnosis of nasopharyngeal tumors | Zendy

Svetlana Stošić-Divjak | Zendy; Vojko Djukić | Zendy; Željko Petrović | Zendy; Vladimir Nešić | Zendy; Alek Racic | Zendy; Zoran Tatić | Zendy; Vladimir Kanjuh | Zendy

Open Access

Possibility of the use of serological method for the determination of immunoglobuline a antibody against early antigene of Epstein-Barr virus as a marker in the diagnosis of nasopharyngeal tumors

Author(s) -

Svetlana Stošić-Divjak,

Vojko Djukić,

Željko Petrović,

Vladimir Nešić,

Alek Racic,

Zoran Tatić,

Vladimir Kanjuh

Publication year - 2005

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp0510739s

Subject(s) - nasopharyngeal carcinoma , medicine , serology , titer , carcinoma , epstein–barr virus , antibody , virus , gastroenterology , tumor marker , immunology , cancer , radiation therapy

According to the data from immunological, biological and molecular researches, there is a close association between the undifferentiated carcinoma of nasopharyngeal type (UCNT) and Epstein-Barr virus (EBV). To use IgA EA antibody as a serological marker in our patients with nasopharyngeal carcinoma from a clinical viewpoint.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research